A Phase 1 Study of STX-0712 in Patients With Advanced Hematological Malignancies (CMML and AML)

Clinical trial NCT06950034 · RECRUITING

Trial details

NCT number: NCT06950034
Sponsor: Solu Therapeutics, Inc
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Chronic Myelomonocytic Leukemia Chronic Myelomonocytic Leukemia (CMML)Chronic Myelomonocytic Leukemia-1 Chronic Myelomonocytic Leukemia-2 Refractory Chronic Myelomonocytic Leukemia CMML Acute Myeloid Leukemia Acute Myeloid Leukemia (AML)Acute Myeloid Leukemia Post Cytotoxic Therapy Acute Myeloid Leukemias Refractory Acute Myeloid Leukemia (AML)Acute Monocytic Leukemia

Start date: 2025-03-13
Primary completion: 2026-12-31
Enrollment: 105

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.